MIR137HG
gene geneOn this page
Summary
MIR137HG (MIR137 host gene, HGNC:42871) is a long non-coding RNA gene on chromosome 1p21.3.
Predicted to be involved in miRNA-mediated post-transcriptional gene silencing. Predicted to be part of RISC complex.
Source: NCBI Gene 400765 — RefSeq curated summary.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:42871 |
| Approved symbol | MIR137HG |
| Name | MIR137 host gene |
| Location | 1p21.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000225206 |
| Ensembl biotype | lncRNA |
| Entrez | 400765 |
| RNAcentral | URS000075CFB2 — lncRNA, 2469 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 17 lncRNA
ENST00000413670, ENST00000424528, ENST00000602672, ENST00000602852, ENST00000602984, ENST00000634594, ENST00000648602, ENST00000667128, ENST00000687457, ENST00000688666, ENST00000716993, ENST00000747904, ENST00000747905, ENST00000747906, ENST00000747907, ENST00000747908, ENST00000747909
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000413670 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004090282 | 98041878 | 98045579 |
Expression profiles
Bgee: expression breadth broad, 97 present calls, max score 81.52.
FANTOM5 (CAGE): breadth broad, TPM avg 2.7336 / max 317.5341, expressed in 513 samples.
FANTOM5 promoters (12 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 13468 | 0.5279 | 77 |
| 13462 | 0.4284 | 263 |
| 13471 | 0.3975 | 96 |
| 13461 | 0.3919 | 187 |
| 13466 | 0.2916 | 127 |
| 13474 | 0.1702 | 61 |
| 13473 | 0.1369 | 56 |
| 13472 | 0.0935 | 48 |
| 13469 | 0.0893 | 27 |
| 13467 | 0.0841 | 24 |
Top tissues by expression
196 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 81.52 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 73.33 | gold quality |
| right frontal lobe | UBERON:0002810 | 71.82 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 71.39 | gold quality |
| prefrontal cortex | UBERON:0000451 | 71.25 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 70.95 | gold quality |
| hypothalamus | UBERON:0001898 | 70.32 | gold quality |
| nucleus accumbens | UBERON:0001882 | 68.02 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 67.74 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 67.36 | gold quality |
| amygdala | UBERON:0001876 | 67.11 | gold quality |
| neocortex | UBERON:0001950 | 67.02 | gold quality |
| frontal cortex | UBERON:0001870 | 66.18 | gold quality |
| stromal cell of endometrium | CL:0002255 | 65.67 | gold quality |
| adenohypophysis | UBERON:0002196 | 65.53 | gold quality |
| cerebral cortex | UBERON:0000956 | 63.42 | gold quality |
| pituitary gland | UBERON:0000007 | 62.93 | gold quality |
| forebrain | UBERON:0001890 | 62.84 | gold quality |
| brain | UBERON:0000955 | 61.97 | gold quality |
| putamen | UBERON:0001874 | 61.90 | gold quality |
| caudate nucleus | UBERON:0001873 | 61.50 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 61.03 | gold quality |
| ventricular zone | UBERON:0003053 | 60.92 | gold quality |
| endothelial cell | CL:0000115 | 60.71 | silver quality |
| colonic epithelium | UBERON:0000397 | 60.57 | silver quality |
| ganglionic eminence | UBERON:0004023 | 59.16 | gold quality |
| upper lobe of lung | UBERON:0008948 | 59.09 | silver quality |
| lower lobe of lung | UBERON:0008949 | 58.76 | silver quality |
| substantia nigra | UBERON:0002038 | 58.59 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 58.56 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-35 | yes | 98.19 |
| E-ANND-3 | yes | 5.25 |
| E-HCAD-30 | no | 571.03 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 8)
- the mechanisms whereby MIR137HGrv works to increase schizophrenia risk are not those that generate the corpus callosum volume reductions commonly found in the disorder. (PMID:26123324)
- Single-nucleotide polymorphism (SNP), rs1625579, within the host gene (MIR137HG) was identified as the top new associated SNP in the first large schizophrenia genome-wide association study. (PMID:26836412)
- decreased white matter integrity of the posterior cingulum in risk allele homozygotes of MIR137 (PMID:30035013)
- Blood and tissue levels of lncRNAs in periodontitis. (PMID:32372456)
- Expression of BDNF-Associated lncRNAs in Treatment-Resistant Schizophrenia Patients. (PMID:33403596)
- The effects of MIR137HG genetic polymorphisms on the susceptibility of alcohol-induced osteonecrosis of the femoral head in a Chinese male population. (PMID:34403773)
- miR-2682-3p antagonizes its host lncRNA-MIR137HG by interacting with the same target FUS to regulate the progression of gastric cancer. (PMID:35733138)
- Impact of MIR137HG rs7554283 on susceptibility to high-altitude pulmonary edema in the Chinese population. (PMID:39439230)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.